The global food allergy diagnostics & therapeutics market size is expected to reach USD 4.71 billion by 2026, exhibiting a CAGR of 7.4%. The market is expected to grow in the coming years owing to increasing incidence of food allergies coupled with rising demand for products for management of these conditions.
Get Exclusive Free Sample Copy Of This Report @ https://www.radiantinsights.com/research/food-allergy-diagnostics-and-therapeutics-market/request-sample
There are more than 160 foods that can lead to allergic reactions; however, only 8 most common allergens have been identified by the FDA. These include eggs, milk, peanuts, soy, tree nuts, wheat, shellfish, and fish. Some of the other allergens are corn, meat, gelatin, seeds, spices, and fruits & vegetables. Based on Food Allergy Research and Education (FARE) 2016 data, around 15 million people in the U.S. have food allergy. Ingestion of any of the common allergens might lead to anaphylaxis, a life-threatening allergic reaction, which might further result in anaphylactic shock. Every year, around 2,000 hospitalizations, 30,000 emergency room visits, and 150 deaths due to anaphylaxis are recorded in the U.S.
However, administering epinephrine using an auto-injector during the early stage of anaphylaxis might help avoid any serious complications. Treatment for food allergy costs around USD 25 billion annually in the U.S. Development of cost-effective in vitro diagnostic tests for detection of allergy is expected to fuel the demand for diagnostic products.
Further key findings from the study suggest:
- Therapeutics segment dominated the market in 2018 due to growing demand for antihistamines and epinephrine auto-injector
- Diagnostic segment includes instruments, consumables, and services, wherein consumables accounted for the largest share in 2018
- The most common tests used to diagnose food allergies are skin prick tests and blood tests
- Peanut allergen source segment is anticipated to register lucrative growth over the forecast period, owing to novel product launches coupled with rising incidence of peanut allergies worldwide.
- Hospitals & clinics dominated the food allergy diagnostics & therapeutics market in 2018 owing to increase in number of hospitalizations due to severe allergic conditions
- Europe held the largest share in 2018 owing to increase in prevalence as well as awareness about various symptoms of food allergic reactions in this region
- Asia Pacific is anticipated to exhibit significant growth during the forecast period due to rising disposable income and incidence of shellfish allergy
- Some of the key companies are Allergy Therapeutics; Cambridge Allergy Ltd; Astellas Pharma, Inc.; Immunomic Therapeutics, Inc.; bioMerieux SA; Omega Diagnostics Group PLC; and HYCOR Biomedical
Browse Complete Report Summary with TOC here https://www.radiantinsights.com/research/food-allergy-diagnostics-and-therapeutics-market
About Radiant Insights
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Media Contact:
Michelle Thoras
201 Spear Street 1100,
Suite 3036, San Francisco,
CA 94105, United States
Tel: 1-415-349-0054
Toll Free: 1-888-928-9744
Mail: [email protected]
For early-stage entrepreneurs in Europe, it’s usually difficult to understand where to turn and how to tell a good venture capital firm from a less good venture capital firm UK.
22 May 2019 - The Global DNA Vaccine Market Research Report includes In-depth Analysis of industry by recent technologies, trends, opportunities, challenges, key players and business strategies considering types, segment, and future analysis.
The DNA Vaccine Market Report Provides Growth History, Sales Channel, Manufacturers Profiled in DNA Vaccine Business, Market Share of Product, Application and Regional Scope of DNA Vaccine which makes the research report a helpful resource for marketing people, forecasters, industry executives & consultants, sales, product managers, Strategy Advisor, potential investors to understand the present as well as future market size, situations in terms of growth rate and revenue.
This report will help the viewer in Better Decision Making.Leading Key Manufacturers – Arbutus Biopharma Co., Sanofi S.A., Vical Ltd., Astellas Pharma, Inc., Dendreon Co., Merck & Co., Invio Biomedical, Inc., and Novartis Animal Health, IncTo get a free sample request at: https://www.millioninsights.com/industry-reports/dna-vaccine-market-insights/request-sampleFactors responsible for the growth of the industry are rise in adoption of personalized medicine applications and DNA identification as a therapy.
The personalised medicine application helps in the treatment of number of chronic diseases, thus driving the need for HLA typing for therapies.
Furthermore, recent technological advancement and increasing adoption of digital services in healthcare sector is leads in increase of commercialization for next generation diagnostics, which is expected to fuel market demand for DNA vaccine over the forecast period.
Rising influence of commercialization and digitalization in healthcare sector are driving the demand for DNA vaccine, in the recent years.Growing popularity of the animal DNA vaccines segment is attributed to the higher approval rate and current development in the field of DNA synthesis, immunology and molecular biology.
The Global Vitiligo Treatment Market is likely to gain impetus from an ever rising demand for innovative and modern treatment options for vitiligo.
According to Fortune Business Insights, titled, “Vitiligo Treatment: Global Market Analysis, Insights and Forecast, 2019-2026,” the global vitiligo treatment market was valued at US$ 1,243.8 Mn in 2018.
The market is projected to reach US$ 1,944.5 Mn by 2026, exhibiting a CAGR of 5.8% in the forecast period.Browse Complete Report Details@ https://www.fortunebusinessinsights.com/industry-reports/vitiligo-treatment-market-100580Some of the Main Key Players Covered in the ReportIncyte CorporationAstellas Pharma Inc.Bausch Health Companies Inc.Baxter International Inc.Pfizer Inc.STRATA Skin SciencesReddy’s Laboratories Ltd.In terms of treatment, the global vitiligo treatment market is grouped into topical treatment, surgical procedures, light therapy, and others.
Amongst these, the topical treatment segment had held majority of the vitiligo treatment market share.
This is because of the increasing patient pool, need for numerous treatment methods for vitiligo, and an increasing number of research and development activities.
However, lack of awareness regarding the available vitiligo treatment and reduction in the diagnosis rate may hamper the vitiligo treatment market growth.Increasing Number of Vitiligo Patients to Favor Growth in Asia PacificThe global vitiligo treatment market is geographically divided into North America, Latin America, the Middle East and Africa, Europe, and Asia Pacific.
According to the new market research report In Vitro Toxicity Testing Market is expected to reach USD 14.9 billion by 2025 from an estimated USD 9.1 billion in 2020, at a CAGR of 10.3%.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=209577065The major factors driving the growth of this in vitro toxicity testing market are the opposition to animal testing, technological advancements, and increasing R expenditure to detect toxicity at an early stage during drug development are the primary growth drivers for this market.Asia Pacific is estimated to be the fastest-growing market for in vitro toxicology testing during the forecast periodThe APAC in vitro toxicology testing market is projected to register the highest growth during the forecast period.
Factors such as emergence of CROs for outsourcing toxicology-related research projects, opposition to animal testing resulting in the use of alternate methods, increasing pharmaceutical drug pipeline, and growing consumer awareness of product safety are some of the key factors driving the growth of the market in the APAC.Due to covid-19 outbreak, there has been a significant increase in Covid-19 testing and drug research.
The research in this area is being further undertaken to understand the dynamics of the infection better, which is expected to propel the in vitro toxicology research field further.
On the other hand, we are estimating that the major share of diagnostic assays and molecular testing of Covid-19, along with personalized medicine will grow at a stable pace in the next five years.
There is a huge increase of manufacturers that have taken key steps to increase patient access to coronavirus diagnostic testing, vaccine and drug development in laboratories, hospitals, and other testing sites across the country to guide patient care and protect public health.Get 10% FREE Customization on this Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=209577065In the toxicity endpoints and tests market, the organ toxicity segment is expected to grow at the highest CAGR during the forecast periodThe organ toxicity segment is expected to grow at the highest CAGR during the forecast period.
The growth in this segment can be attributed to factors such as the increasing focus on drug safety and consumer-product safety, along with the need to screen potential drug targets during the early stage of drug development.Based on the technologies used in the in vitro toxicology testing, the cell culture technologies segment is expected to account for the largest share of the in vitro toxicology testing marketThe cell culture technologies segment is estimated to account for the largest market share in 2018.
